Detalles de la búsqueda
1.
An Analysis of New Health Technologies and Reimbursement Pricing Structures in Taiwan.
Value Health
; 17(7): A725, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202581
2.
The Differences Between Cancer Drug Approvals in Japan and the USA.
Value Health
; 17(7): A739, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202656
3.
The Differences Between Infectious & Parasitic Drug Approvals in Japan and the USA.
Value Health
; 17(7): A808, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27203049
4.
Analysing The Effects of a Disinvestment Decision in Breast Cancer Screening Programmes in Asia-Pacific Countries: A Modelling Approach.
Value Health
; 17(7): A735, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202633
5.
Closing the Gap: Reduced Delay to Drug Marketing Approval Between The West and Asia.
Value Health
; 17(7): A776, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202868
6.
Burden of Disease in Asian Countries and the use of Disability-Adjusted Life-Years and Quality-Adjusted Life-Years.
Value Health
; 17(7): A751, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202727
7.
Impact Of Ethnicity On The Efficacy And Safety Outcomes Of Anti-Diabetes Drugs - Case Study Of Liraglutide In Asian And Non-Asian Populations.
Value Health
; 17(7): A742, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202675
Resultados
1 -
7
de 7
1
Próxima >
>>